UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
Current Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 21, 2017
EMR TECHNOLOGY SOLUTIONS INC.
(Exact name of registrant as specified in its charter)
| Nevada | 000-55715 | 47-5482792 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
90 Washington Valley Road
Bedminster, New Jersey 07921
(Address of principal executive offices)
(908) 997-0617
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging Growth Company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
EXPLANATORY NOTE
On March 21, 2017, EMR Technology Solutions, Inc., a Nevada corporation (the “Company”) filed a Current Report on Form 8-K (the “March 8-K”) with the Securities and Exchange Commission to report the purchase by the Company of Digital Medical Solutions, Inc., a Nevada corporation (“DMSI”).
The Company is filing this Current Report on Form 8-K to disclose the financial statements and pro forma financial information required by parts (a) and (b) of Item 9.01 of Form 8-K for DMSI. The Company hereby amends the March 8-K in order to include the required financial statements and pro forma financial information.
| Item 9.01 | Financial Statements and Exhibits |
(a) Financial statements of business acquired
The audited financial statements of DMSI as of and for the year ended December 31, 2016 and the notes thereto, and pro forma financial information are filed as Exhibit 99.1 and Exhibit 99.2, respectively hereto, and are incorporated herein by reference.
(d) Exhibits
The following exhibits are filed with this report:
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| EMR TECHNOLOGY SOLUTIONS INC. | |
| Date: February 15, 2018 | /s/ John X. Adiletta |
| Name: John X. Adiletta | |
| Title: Chief Executive Officer |
2
